Coat Protein Complex I: Clinical Trials

3 trials of Coat Protein Complex I, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 unknown. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 1, Terminated 1, Unknown 1

Follow Coat Protein Complex I: new trials by email Literature Review of Coat Protein Complex I trials Research Report on Coat Protein Complex I

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone
fingolimod, glatiramer acetate - Relapsing-remitting Multiple Sclerosis (RRMS)
Phase 3TerminatedNovartis Pharmaceuticals10642012-08-092019-05-28
Investigating the Neuroprotective Effect of Cop-1 (Copaxone) in Acute Primary Angle Closure
Copaxone, Placebo (buffered normal saline w/v) - Glaucoma, Angle-closure, Primary, Acute
Phase 3UnknownSingapore Eye Research Institute1962010-09-012013-09-06
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple Sclerosis
copolymer 1 - Multiple Sclerosis
Phase 3CompletedNational Center for Research Resources (NCRR)2501991-10-012005-06-24

Conditions studied

Glaucoma (1)  ·  Mental Disorders (1)  ·  Multiple Sclerosis (1)  ·  Multiple Sclerosis, Relapsing-Remitting (1)  ·  Neurologic Manifestations (1)  ·  Rare Diseases (1)

Sponsors

National Center for Research Resources (NCRR) (1)  ·  Novartis Pharmaceuticals (1)  ·  Singapore Eye Research Institute (1)

Countries

Argentina (1)  ·  Brazil (1)  ·  Canada (1)  ·  Chile (1)  ·  Mexico (1)  ·  Puerto Rico (1)  ·  Singapore (1)  ·  United States (1)

Top investigators

Kenneth P. Johnson (1)  ·  Tin Aung, FRCOphth,PhD (1)

Results publications

PMID 32852530